ESPR vs SIGA โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
ESPR Captures Institutional Edge (3โ1 Pillars ยท 7โ3 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Esperion Therapeutics, Inc. (ESPR) driven by superior Growth & Margin, Momentum & Technical, Options & Structure while SIGA counters with relative strength in Valuation. Fundamentally, ESPR trades at 10.9x Forward P/E with -8.2% operating margin (+23.2% YoY revenue) versus SIGA at 2.3x Forward P/E and -14.2% operating margin (-49.7% YoY). In options structure, ESPR sits in UNCLASSIFIED (9th %ile IV; Dealer Gamma Walls on Pro) against SIGA sits in BREAKDOWN (6th %ile IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | ESPR Revenue | SIGA Revenue | ESPR Op. Margin | SIGA Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2018 | N/A | $480M | N/A | 74.4% | SIGA |
| FY2019 | $150M | $30M | -62.8% | -8.7% | SIGA |
| FY2020 | $230M | $120M | -53.3% | 67.6% | SIGA |
| FY2021 | $80M | $130M | -289.0% | 66.7% | SIGA |
| FY2022 | $80M | $110M | -237.8% | 38.5% | SIGA |
| FY2023 | $120M | $140M | -133.7% | 59.8% | SIGA |
| FY2024 | $330M | $140M | 16.4% | 50.4% | SIGA |
| FY2025 | $400M | $90M | 15.0% | 25.1% | SIGA |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | ESPR | SIGA | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $822.0M | $188.3M | Larger Scale | ESPR |
| Trailing P/E Ratio Valuation | 4.6x | N/M | Lower Multiple | ESPR |
| Forward P/E Ratio Valuation | 10.9x | 2.3x | Lower Multiple | SIGA |
| Revenue Growth (YoY) Growth | +23.2% | -49.7% | Higher Growth | ESPR |
| Operating Margin (TTM) Profitability | -8.2% | -14.2% | Higher Margin | ESPR |
| Net Profit Margin Profitability | -1.8% | 1.3% | Higher Margin | SIGA |
| Return on Equity (ROE) Capital Efficiency | -260.8% | 0.4% | Higher ROE | SIGA |
| 52-Week Range Position Momentum | 68% ($1โ$4) | 2% ($2โ$7) | Stronger Trend | ESPR |
| Beta / 30D Volatility Risk Regime | 1.86ฮฒ ยท 6% Vol | 0.90ฮฒ ยท 74% Vol | Lower Realized Risk | ESPR |
| Unified Institutional Score Composite Signal | 60.0 / 100 (BUY) | 46.2 / 100 (HOLD) | Higher Composite | ESPR |